{"resourceType":"ImplementationGuide","id":"hl7.fhir.us.pq-cmc-fda","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status","valueCode":"trial-use"},{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-wg","valueCode":"brr"},{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm","valueInteger":2}],"url":"http://hl7.org/fhir/us/pq-cmc-fda/ImplementationGuide/hl7.fhir.us.pq-cmc-fda","version":"3.0.0","name":"FHIR_pqcmc_fda","title":"Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA","status":"active","publisher":"HL7 International / Biomedical Research and Regulation","contact":[{"name":"HL7 International / Biomedical Research and Regulation","telecom":[{"system":"url","value":"http://www.hl7.org/Special/committees/rcrim"},{"system":"email","value":"brr@lists.HL7.org"}]}],"description":"The FDA PQ-CMC FHIR IG is for submission of structured and standardized information regarding drug product quality, chemistry, manufacturing and processes controls.\u00a0 This data is intended for submission to the US FDA by biopharmaceutical companies for the purpose of drug application review.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US","display":"United States of America"}]}],"packageId":"hl7.fhir.us.pq-cmc-fda","license":"CC0-1.0","fhirVersion":["5.0.0"],"dependsOn":[{"id":"hl7_terminology_r5","uri":"http://terminology.hl7.org/ImplementationGuide/hl7.terminology","packageId":"hl7.terminology.r5","version":"6.2.0"}],"definition":{"resource":[{"reference":{"reference":"Bundle/DescriptionCompositionBundle"},"name":"3.2.P.1.0 Bundle","description":"Description and Composition of the Drug Product bundle","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32p10"},{"reference":{"reference":"Bundle/BatchFormulaBundle"},"name":"3.2.P.3.2 Bundle for liquid","description":"Batch Formula bundle for a liquid drug product","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32p32"},{"reference":{"reference":"Bundle/BatchFormulaBundle2Layer"},"name":"3.2.P.3.2 Bundle for two-layer tablet","description":"Batch Formula bundle for a tablet drug product with two layers","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32p32"},{"reference":{"reference":"Bundle/SpecificationExcipientBundle"},"name":"3.2.P.4 Bundle","description":"Specification bundle for an Excipient substance","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-sp4151"},{"reference":{"reference":"Bundle/SpecificationProductBundle"},"name":"3.2.P.5.1 Bundle","description":"Specification bundle for a Drug Product","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-sp4151"},{"reference":{"reference":"Bundle/CharacterisationImpuritiesProductBundle"},"name":"3.2.P.5.5 Bundle","description":"Product Characterisation of Impurities bundle","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32p55"},{"reference":{"reference":"Bundle/CharacterisationImpuritiesBundle"},"name":"3.2.P.5.5 Bundle 2","description":"Product Characterisation of Impurities bundle - example 2","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32p55"},{"reference":{"reference":"Bundle/GeneralInformationBundle"},"name":"3.2.S.1 Bundle","description":"General Information bundle","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32s10"},{"reference":{"reference":"Bundle/ControlMaterialsBundle"},"name":"3.2.S.2.3 Bundle","description":"Control of Materials bundle","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32s23"},{"reference":{"reference":"Bundle/CharacterisationBundle"},"name":"3.2.S.3 Bundle","description":"Substance Characterisation bundle","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32s3"},{"reference":{"reference":"Bundle/SpecificationSubstanceBundle"},"name":"3.2.S.4.1 Bundle","description":"Specification bundle for an API substance","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-sp4151"},{"reference":{"reference":"StructureDefinition/pq-additional-info-extension"},"name":"Additional Information","description":"Any additional information that that the submitter wishes to provide to the FDA that is not structured in the IG. The content of the information submitted via Additional Information may be analyzed at some point in the future, to identify candidate elements for structuring in future iterations of the IG.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-amount-ratio"},"name":"Amount Ratio","description":"The fields needed to represent an amount as a ratio.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-graphic-attachment"},"name":"Analysis Graphic","description":"Any attached file that contains a graphical representation","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-analytical-intstrument-data"},"name":"Analytical Instrument Data","description":"Any attached file that contains analytical instrument data","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-analytical-instrument-data-types"},"name":"Analytical Instrument Data File Types","description":"The acceptable file types that can be used in Analytical Instrument Data Files","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-pdf-attachment"},"name":"Attached Document (PDF)","description":"An attached PDF file","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-organization"},"name":"Basic Organization","description":"A profile for the data elements required to identify the sponsor and/or the supplier of the drug products or substances.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-batch-analysis"},"name":"Batch Analysis","description":"Batch or lot release testing  to ensure that pharmaceutical products meet the product specification.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-batch-formula-product"},"name":"Batch Formula Drug Product Identification","description":"The Drug Product produced by the batch formula.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-batch-utilization-terminology"},"name":"Batch utilization Terminology","description":"Terminology used to qualify the information pertaining to batch utilization in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/capsule-classification-category"},"name":"Capsule Shell Classification  Terminology","description":"A category of terminology used to qualify the information pertaining to the classification of a capsule in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-chemical-structure-datafile-type-terminology"},"name":"Chemical Structure Data File Type Terminology","description":"Terminology used to qualify the information pertaining to chemical structure data file types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-closure-type-terminology"},"name":"Closure Type Terminology","description":"Terminology used to qualify the information pertaining to closure types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32p10"},"name":"CMC eCTD 32P10 Document","description":"Definition for a document bundle with the CMC eCTD 32P1 profiles (Description and Composition of the Drug Product).","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32p32"},"name":"CMC eCTD 32P32 Document","description":"Definition for a document bundle with the CMC eCTD 32P32 profiles (Product Batch Formula).","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32p55"},"name":"CMC eCTD 32P55 Document","description":"Definition for a document bundle with the CMC eCTD 32P55 profile (Product Characterisation of Impurities).","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32p70"},"name":"CMC eCTD 32P70 Document","description":"Definition for a document bundle with the CMC eCTD 32P70 profiles.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32s10"},"name":"CMC eCTD 32S10 Document","description":"Definition for a document bundle with the CMC eCTD 32S1 profiles (General Information).","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32s23"},"name":"CMC eCTD 32S23 Document","description":"Definition for a document bundle with the CMC eCTD 32S23 profiles (Substance Control of Materials).","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32s3"},"name":"CMC eCTD 32S3 Document","description":"Definition for a document bundle with the CMC eCTD 32S3 profiles (Substance Characterisation).","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32s60"},"name":"CMC eCTD 32S60 Document","description":"Definition for a document bundle with the CMC eCTD 32S60 profiles.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-sp4151"},"name":"CMC eCTD SP4151 Document","description":"Definition for a document bundle with the CMC eCTD SP4151 profiles (Specification).","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-sp4454"},"name":"CMC eCTD SP4454 Document","description":"Definition for a document bundle with the CMC eCTD SP4454 profiles.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-sp7181"},"name":"CMC eCTD SP7181 Document","description":"Definition for a document bundle with the CMC eCTD SP7181 profiles.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-sp7383"},"name":"CMC eCTD SP7383 Document","description":"Definition for a document bundle with the CMC eCTD SP7383 profiles.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-coating-purpose"},"name":"Coating Purpose Terminology","description":"A category of terminology used to qualify the information pertaining to the coating purpose in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-component-substance"},"name":"Component Substance","description":"Any raw material intended for use in the manufacture of a drug substance, or any ingredient intended for use in the manufacture of a drug product including those that may not appear in such drug product.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-conformance-to-criteria-terminology"},"name":"Conformance to Criteria Terminology","description":"Terminology used to qualify the information pertaining to conformance to criteria in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-container-orientation-terminology"},"name":"Container Orientation Terminology","description":"Terminology used to qualify the information pertaining to container orientation in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-container-type-terminology"},"name":"Container Type Terminology","description":"Terminology used to qualify the information pertaining to container types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ContainerClosure"},"name":"ContainerClosure","description":"Container Closure for drug product referred to in Drug Product Description.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-document-reference"},"name":"Document Reference Attachment","description":"A profile that represents the document or diagram in base64.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-product-batch-formula"},"name":"Drug Product Batch Formula","description":"Listing of all components of the dosage form to be used in the manufacture, their amounts on a per batch basis, including overages, and reference to their quality standards.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-dp-ingredient"},"name":"Drug Product Batch Formula Ingredient","description":"The amount details about the drug product ingredients in the batch. Use for Batch Formula.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-component"},"name":"Drug Product Component","description":"The amount details about the drug product components to define the product composition in a product unit. Use composition.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-drug-product-component-function-category-terminology"},"name":"Drug Product Component Function Category Terminology","description":"Terminology used to qualify the information pertaining to drug product component function categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-product-description"},"name":"Drug Product Description","description":"Includes the properties of the drug product and components. Profile of Drug Product profile.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-product-handle"},"name":"Drug Product Handle","description":"Includes the essential identifying information of the drug product required to link to other profiles about the product in the eCTD structure. Profile on MedicinalProductDefinition.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-product-with-impurities"},"name":"Drug Product Impurities","description":"List of drug product impurities. Profile of Drug Product profile.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-product-instance"},"name":"Drug Product Manufactured Instance","description":"Includes the properties of the drug product as manufactured.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/drug-product-manufacturing-batch"},"name":"Drug Product Manufacturing Batch","description":"This profile defines the details of a batch of medicine.","exampleBoolean":false},{"reference":{"reference":"ValueSet/spl-drug-route-of-administration-terminology"},"name":"Drug Route Of Administration Terminology","description":"Terminology used for representation of the information on pharmaceutical product route of administration in the framework of the Structured Product Labeling documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-substance-characterisation"},"name":"Drug Substance","description":"Drug Substance (Active Ingredient) nomenclature and characterization.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-substance-container-closure"},"name":"Drug Substance Container Closure","description":"Description and coding of the container closure system.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-routine-drug-substance"},"name":"Drug Substance Handle","description":"Includes the essential identifying information of the drug substance required to link to other profiles about the substance in the eCTD structure. Profile on SubstanceDefinition.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-product-substance-impurity"},"name":"Drug Substance Impurity","description":"Any component of the drug substance that is not the chemical entity for product composition.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-substance-batch"},"name":"Drug Substance Manufactured Batch","description":"Includes the properties of the drug substance as manufactured.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/drug-substance-manufacturing-batch"},"name":"Drug Substance Manufacturing Batch","description":"This profile defines the details of a batch of API.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-sp4454"},"name":"eCTD Batch Analyses Composition","description":"The fields needed to represent the Batch Analyses to be included under the 3.2.P.5.4 and 3.2.S.4.4 eCTD headings.  References Sponsor Organization and Batch Analysis","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32p32"},"name":"eCTD Batch Formula","description":"The fields needed to represent the Product Batch Formula to be included under the eCTD. References Sponsor Organization and Batch Formula","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32p55"},"name":"eCTD Product Characterisation of Impurities","description":"The fields needed to represent the Product Characterisation of Impurities in a EctdComposition32P55 to be included under the eCTD. References Sponsor Organization and Product Characterisation of Impurities","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32p70"},"name":"eCTD Product Container Closure System Composition","description":"The fields needed to represent the Product Container Closure Systems to be included under the eCTD p.7.0","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32p10"},"name":"eCTD Product Description and Composition","description":"The fields needed to represent the Product Description, Container Closure and Composition of the Drug Product to be included under the 3.2.P.1 heading of the eCTD. References Sponsor Organization, Drug Product Description, and Product Container Closure System.","exampleBoolean":false},{"reference":{"reference":"ValueSet/cmc-comp-section-types-vs"},"name":"eCTD sections Terminology","description":"Value set of all codes in Code system PQCMC Comp Section Types.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-sp4151"},"name":"eCTD Specification","description":"The fields needed to represent Quality Specifications for APIs, Drug Substances, Excipients and Raw Materials.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-sp7383"},"name":"eCTD Stability Data Composition","description":"The fields needed to represent the Stability Data to be included under the 3.2.P.8.3 , 3.2.S.7.3 and 3.2.P.4.5 eCTD headings. References Sponsor Organization and Stability Study.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-sp7181"},"name":"eCTD Stability Summary and Conclusion Composition","description":"The fields needed to represent the Stability Summary and Conclusion to be included in the 3.2.P.8.3 and 3.2.S.7.3 eCTD headings. References Sponsor Organization and Stability Study.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32s3"},"name":"eCTD Substance Characterisation","description":"The fields needed to represent the Substance Structure and Impurities to be included under the 3.2.S.3 heading of the eCTD. References Sponsor Organization, Drug Substance Structure, and Drug Substance Impurities","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32s60"},"name":"eCTD Substance Container Closure System Composition","description":"The fields needed to represent the Substance Container Closure Systems to be included under the eCTD 3.2.S.6.0 eCTD heading. References Sponsor Organization and Substance Container Closure","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32s23"},"name":"eCTD Substance Control of Materials","description":"The fields needed to represent the Substance Control of Materials to be included under the eCTD 3.2.S.2.3 heading. References Sponsor Organization and Drug Substance Materials.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32s10"},"name":"eCTD Substance General Information","description":"The fields needed to represent the Substance Nomenclature and Structure to be included under the 3.2.S.1 heading of the eCTD. References Sponsor Organization.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-excipient"},"name":"Excipient Drug Substance","description":"Provides sufficient information to identify an inactive substance and raw materials and its source when stability data is required in the submission.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-excipient-function-terminology"},"name":"Excipient Function Terminology","description":"Terminology used to qualify the information pertaining to excipient functions in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-expiration-date-classification-terminology"},"name":"Expiration Date Classification Terminology","description":"Terminology used to qualify the information pertaining to expiration date classification functions in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-genc-and-iso-intersect"},"name":"GENC and ISO 3166 Intersection","description":"The 3 letter country codes used in GENC and ISO have significant overlap: only the country codes in ISO 3166 that have an equivalent code in GENC may be used","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-graphic-reference"},"name":"Graphic Reference","description":"A Document Reference to any attachment that contains a graphical representation","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-graphical-file-types"},"name":"Graphical File Types","description":"The acceptable file types that can be used in graphical files","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-hierarchical-level-extension"},"name":"Hierarchical Level","description":"Numeric level in the hierarchical value-set. As an example, this extension is used to distinguish between Test Category | Test Subcategory in Quality Specifications. Test Category is level 1 and Test Subcategory is level two. A constraint enforces values greater than zero. ","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-impurity-classification-terminology"},"name":"Impurity Classification Terminology","description":"Terminology used to qualify the information pertaining to impurity classifications in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-product-part-ingredient-physical-location"},"name":"Ingredient Location Terminology","description":"A category of terminology used to qualify the information pertaining to the location of an ingredient within a product in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-interval-description-code-terminology"},"name":"Interval Description Code Terminology","description":"Terminology used to qualify the information pertaining to interval description codes in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/literal-codeable-reference"},"name":"Literal Coded Reference","description":"An abstract profile to ensure the reference portion of a codeable reference is used, and that the reference is a literal reference to some resource in a bundle","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/literal-reference"},"name":"Literal Reference","description":"An abstract profile to ensure the reference is always a literal reference. Used in conjunction with a rule set to ensure every reference is also bundled.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-manufactured-dose-form-terminology"},"name":"Manufactured Dose Form Terminology","description":"Terminology used to qualify the information pertaining to the manufactured dose form.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-product-part"},"name":"Manufactured Drug Product","description":"The manufactured drug product defined by all its parts or layers. If the drug product composition is homogeneous it will have a single part or component.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-additional-stage-result-observation"},"name":"Multiple Result Observation","description":"Profile for an observation in a batch-analysis report or a stability report","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-non-percentage-units"},"name":"Non-Percentage Units","description":"Units of Measure terminologies that do not represent percentages","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-overage-extension"},"name":"Overage Extension","description":"Extension for measurements related to excess for ingredients in the batch formula.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/packaged-product-substance-reference"},"name":"Packaged Product Substance Reference","description":"Modifier extension to reference a SubstanceDefinition from PackagedProductDefinition, not a MedicinalProductDefinition","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-percentage-units"},"name":"Percentage Units","description":"Units of Measure terminologies that represent the concept of a percentage","exampleBoolean":false},{"reference":{"reference":"ValueSet/spl-pharmaceutical-dosage-form-terminology"},"name":"Pharmaceutical Dosage Form Terminology","description":"Terminology used for representation of the information on pharmaceutical product dosage form in the framework of the SPL documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-polymorphic-form"},"name":"Polymorphic Form","description":"Alternate structure present in the drug substance","exampleBoolean":false},{"reference":{"reference":"CodeSystem/cmc-hierarchy-supplement"},"name":"PQ-CMC-FDA NCIt Hierarchy Supplement","description":"Provides hierarchical relationships for value sets as a CodeSystem supplement to the NCI Thesaurus (NCIt) ","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-cmc-address"},"name":"PqAddress","description":"pq-specific Constraints on the Address datatype dealing with US addresses.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-attachment"},"name":"PQCMC Attachment","description":"Any attached file in a submission is required to have a type, data, and a title","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-name-part-terminology"},"name":"PQCMC Name Part Terminology","description":"Terminology used to qualify the information pertaining to Name Part data in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-product-batch-strength-textual-extension"},"name":"Product Batch Strength Textual Extension","description":"Extension for strength as a string for ingredients in the batch formula.","exampleBoolean":false},{"reference":{"reference":"ValueSet/cmc-product-name-types-vs"},"name":"Product Name Types Terminology","description":"The type of the product name. Often the proprietary name is unknown at the time of submission.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-product-part-type"},"name":"Product Part Type Terminology","description":"A category of terminology used to qualify the information pertaining to the product part type in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-pullDate-extension"},"name":"Pull Date","description":"Contains elements related to the pull date of the study samples in a stability study.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-quality-benchmark-terminology"},"name":"Quality Benchmark Terminology","description":"Terminology used to qualify the information pertaining to quality benchmarks in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-quality-specification"},"name":"Quality Specification","description":"A quality specification is for a drug product or drug substance (excipient, API or raw material).","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-quality-specification-extension"},"name":"Quality Specification Reference","description":"The product specification used in the batch release or stability testing.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-release-mechanism"},"name":"Release Mechanism Terminology","description":"A category of terminology used to qualify the information pertaining to release mechanism in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-release-profile"},"name":"Release Profile Terminology","description":"A category of terminology used to qualify the information pertaining to release profile in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-replicate-extension"},"name":"Replicate Number","description":"An identification number for a member of the set of results for a test, usually the sequence order in which the test was executed. Individual tests are executed on multiple samples to give greater validity to the findings. [Source SME Defined] Examples: Prepare six aliquots from the sample. Test 8 samples. If any fall above 110%, test an additional 7 samples. Record all replicate values as stated in the method.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-representation-types"},"name":"Representation Types","description":"The different types of representations (graphical, structure/file and structure/text)","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-result-observation"},"name":"Result Observation","description":"Profile for an observation in a batch-analysis report or a stability report","exampleBoolean":false},{"reference":{"reference":"DocumentReference/de75e338-626c-4503-a25d-4fcdd8e39bee"},"name":"SDF File in a Structure Reference","description":"A sample SDF file that can be referenced from the bundle profiles","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-structure-reference"},{"reference":{"reference":"ValueSet/pqcmc-source-type-terminology"},"name":"Source Type Terminology","description":"Terminology used to qualify the information pertaining to source types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/cmc-specification-types-vs"},"name":"Specification Section Type Terminology","description":"Local value set of all codes in Specification Type codes","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-specification-status-extension"},"name":"Specification Status","description":"A classification of the regulatory status of the specification.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-specification-status-terminology"},"name":"Specification Status Terminology","description":"Terminology used to qualify the information pertaining to specification statuses in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-specification-type-terminology"},"name":"Specification Type Terminology","description":"Terminology used to qualify the information pertaining to specification types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-stability-study"},"name":"Stability Study","description":"Profile for the main stability study.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-stability-study-interval-report"},"name":"Stability Study Interval Report","description":"Batch or lot stability testing to ensure that pharmaceutical products continue to meet the product specification or determine the expiry period.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-stability-study-reason-terminology"},"name":"Stability Study Reason Terminology","description":"Terminology used to qualify the information pertaining to stability study reason data in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-stability-sub-study"},"name":"Stability Sub-Study","description":"Profile for the a stability sub-study.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-stability-summary"},"name":"Stability Summary","description":"Summary of the types of studies conducted (forced degradation, photostability, and stress testing), protocols used, and the results of the studies","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-storage-condition-category-terminology"},"name":"Storage Condition Category Terminology","description":"A classification of storage conditions (temperature and humidity) that is designed to check the chemical degradation or physical change of a drug substance or drug product. [Source: SME Defined]","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-storage-conditions-terminology"},"name":"Storage Conditions Terminology","description":"Terminology used to qualify the information pertaining to storage conditions in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/strength-extension"},"name":"Strength Extension","description":"Strength Type (for API)","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-strength-type-terminology"},"name":"Strength Type Terminology","description":"Terminology used to qualify the information pertaining to strength types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-structure-data"},"name":"Structure Data","description":"Any attached file that contains structure data (e.g. SDFiles, MolFiles, INCHI)","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-structure-reference"},"name":"Structure Data Reference","description":"A Document Reference to any attachment that contains structure data","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-structure-data-types"},"name":"Structure Data Types","description":"The acceptable file types that can be used in Structure Data Files (MOL,SDF,INCHI,etc)","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-timePoint-extension"},"name":"Study Interval","description":"Contains elements related to the intervals of the stability study.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-protocol-extension"},"name":"Study Protocol","description":"Study protocol identification","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-study-type-terminology"},"name":"Study Type Terminology","description":"Terminology used to qualify the information pertaining to study types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/substance-classification"},"name":"Substance Classification","description":"Substance classes","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-substance-nomenclature-structure"},"name":"Substance General Information","description":"Substance General Information containing Drug Substance (Active Ingredient) nomenclature (3.2.S.1.1) and Substance Structure (3.2.S.1.2) profile.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-substance-name-type"},"name":"Substance Name Type","description":"A category of terminology used to qualify the information pertaining to the type of substance name in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-target-range"},"name":"Target Range","description":"The FHIR Range datatype uses Simple Quantities to represent the high and low bounds, which do not allow a comparator to be set. This extension allows the high and low bounds to have a comparator","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-test-category-terminology"},"name":"Test Category Terminology","description":"Terminology used to qualify the information pertaining to test categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-test-method-origin-terminology"},"name":"Test Method Origin Terminology","description":"Terminology used to qualify the information pertaining to test method origins in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-test-usage-terminology"},"name":"Test Usage Terminology","description":"Terminology used to qualify the information pertaining to test usage in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/codeable-concept-text-only"},"name":"Text Only Codeable Concept","description":"An abstract profile for the common scenario where only the text field is used and is required. Doesn't stop the coding portion from being used but it will not be parsed","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-units-of-measure"},"name":"Units Of Measure","description":"Terminology used to qualify the information pertaining to units of measure in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.\r\nNote: Includes SPL Unit of Presentation Terminology","exampleBoolean":false}],"page":{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"toc.html"}],"nameUrl":"toc.html","title":"Table of Contents","generation":"html","page":[{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"index.html"}],"nameUrl":"index.html","title":"Home","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"instruction.html"}],"nameUrl":"instruction.html","title":"General Instructions","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32S10.html"}],"nameUrl":"eCTD32S10.html","title":"General Information (3.2.S.1)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32S23.html"}],"nameUrl":"eCTD32S23.html","title":"Substance Control of Materials (3.2.S.2.3)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32S3.html"}],"nameUrl":"eCTD32S3.html","title":"Substance Characterisation (3.2.S.3)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTDSP4151.html"}],"nameUrl":"eCTDSP4151.html","title":"Specification (3.2.S.4.1, 3.2.P.4 and 3.2.P.5.1)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32P10.html"}],"nameUrl":"eCTD32P10.html","title":"Description and Composition of the Drug Product (3.2.P.1)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32P32.html"}],"nameUrl":"eCTD32P32.html","title":"Product Batch Formula (3.2.P.3.2)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32P55.html"}],"nameUrl":"eCTD32P55.html","title":"Product Characterisation of Impurities (3.2.P.5.5)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32S60.html"}],"nameUrl":"eCTD32S60.html","title":"Substance Container Closure System (3.2.S.6.0)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTDSP4454.html"}],"nameUrl":"eCTDSP4454.html","title":"Batch Analyses (3.2.S.4.4 & 3.2.P.5.4)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTDSP7181.html"}],"nameUrl":"eCTDSP7181.html","title":"Stability Summary (3.2.S.7.1 & 3.2.P.8.1)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTDSP7383.html"}],"nameUrl":"eCTDSP7383.html","title":"Stability Data (3.2.S.7.3 & 3.2.P.8.3)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"artifacts.html"}],"nameUrl":"artifacts.html","title":"Artifact List","generation":"html"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"downloads.html"}],"nameUrl":"downloads.html","title":"Downloads","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"change_notes.html"}],"nameUrl":"change_notes.html","title":"Change Notes","generation":"markdown"}]},"parameter":[{"code":"copyrightyear","value":"2021+"},{"code":"releaselabel","value":"STU3-dev"},{"code":"releaselabel","value":"true"},{"code":"excludettl","value":"true"},{"code":"excludemap","value":"true"},{"code":"apply-wg","value":"true"},{"code":"jira-code","value":"pq-cmc"},{"code":"auto-oid-root","value":"2.16.840.1.113883.4.642.40.36"},{"code":"special-url","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl - https://www.uniprot.org - urn:oid:1.3.6.1.4.1.5193 - http://unitsofmeasure.org - urn:oid:1.3.6.1.4.1.519.1 - urn:oid:2.16.840.1.113883.4.82 - https://www.fda.gov/drugs/drug-approvals-and-databases/drug-establishments-current-registration-site - urn:ietf:rfc:3986"},{"code":"path-history","value":"http://hl7.org/fhir/us/pq-cmc-fda/history.html"}]}}